Last Updated: June 24, 2026

List of Excipients in API DEXAMETHASONE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing DEXAMETHASONE

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Allergan Inc OZURDEX dexamethasone 0023-3348 DL-LACTIDE AND GLYCOLIDE
Novartis Pharmaceuticals Corporation MAXIDEX dexamethasone 0078-0925 BENZALKONIUM CHLORIDE
Novartis Pharmaceuticals Corporation MAXIDEX dexamethasone 0078-0925 CITRIC ACID MONOHYDRATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for DEXAMETHASONE

Excipient focus: ACETYLTRIETHYL CITRATE

Excipient focus: ALCOHOL

Excipient focus: ALUMINUM OXIDE

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: ANHYDROUS TRISODIUM CITRATE

Excipient focus: AQUA

Excipient focus: BENZALKONIUM CHLORIDE

Excipient focus: BENZOIC ACID

Excipient focus: BENZYL ALCOHOL

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CHERRY

Excipient focus: CI 42090

Excipient focus: CITRIC ACID

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: CREATININE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: D&C RED NO. 27

Excipient focus: D&C RED NO. 27 ALUMINUM LAKE

Excipient focus: D&C YELLOW NO. 10

Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient focus: DL-LACTIDE AND GLYCOLIDE

Excipient focus: EDETATE DISODIUM

Excipient focus: EDETATE SODIUM

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE

Excipient focus: FD&C BLUE NO. 1--ALUMINUM LAKE

Excipient focus: FD&C GREEN NO. 3

Excipient focus: FD&C RED NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 5

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: FLUORESCEIN

Excipient focus: GLYCERIN

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSES

Excipient focus: KI203

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LYSYLLYSYLLYSINE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTODEXTRIN

Excipient focus: METHYLPARABEN

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: MINERAL OIL

Excipient focus: NITROGEN

Excipient focus: PETROLATUM

Excipient focus: PHENETHYL ALCOHOL

Excipient focus: PHENYLETHYL ALCOHOL

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYSORBATE 80

Excipient focus: POVIDONE K30

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: RASPBERRY

Excipient focus: RAW SUGAR

Excipient focus: SACCHARIN SODIUM

Excipient focus: SODIUM BISULFITE

Excipient focus: SODIUM BORATE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM METABISULFITE

Excipient focus: SODIUM PHOSPHATE, DIBASIC

Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: SODIUM PHOSPHATE, MONOBASIC

Excipient focus: SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SODIUM SULFITE

Excipient focus: SORBITOL

Excipient focus: SORBITOL SOLUTION

Excipient focus: STARCH, CORN

Excipient focus: STEARIC ACID

Excipient focus: SUCROSE

Excipient focus: TRISODIUM CITRATE

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: WATER

Excipient focus: ZEA MAYS

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links